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Abstract
Diabetes Mellitus is a very common, costly and manageable chronic disease, posing a major
public health concern in the United States. The Center for Disease Control (CDC), 2015,
estimate that one million Americans are living with diabetes; with Type 1 diabetes accounting for
about 5% of all cases diagnosed with diabetes. The American Diabetes Association (ADA),
defines type 1 diabetes as “beta-cell destruction, usually leading to absolute destruction of beta
cells of pancreas usually leading to absolute insulin deficiency.” Patients with DM especially
type 1 diabetic patients, need thorough evaluations before, during and after surgery due to the
high complexity and risk of perioperative infections, cardiovascular morbidity and mortality after
surgery. This case report and literature review will highlight the management of the type 1
diabetic patient during the perioperative and postoperative phase of surgery. Proper
perioperative management of the surgical adult with type 1 diabetes is aimed at decreasing
adverse cardiovascular events, morbidity and mortality, reducing prolonged hospitalizations and
overall cost.
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Background
With about one million type 1 diabetic patients in the United States today, the ADA,
2016, estimates that about 25%-50% of diabetic patients will need surgery at some point in their
lives. Compared to nondiabetic persons, diabetic patients account for a greater majority of the
surgical population annually, with increased mortality rates up to 5 times more than in
nondiabetic patients (ADA, 2016). About 21% of adults 60 years of age and older have diabetes,
with this number expected to double by 2025 (Vann, 2009). The ADA,2016, estimated the total
cost of diagnosed diabetes in the United States in 2012 at $245 billion, with direct medical cost
at $176 billion resulting in $69 billion of reduced productivity.
My case report presents a 67 year old Caucasian male with type 1 diabetes who is being
evaluated for a right total knee replacement and has an insulin pump. Thorough assessment,
planning and coordination with the patient’s endocrinologist and diabetic team during the
perioperative period is very important. This is because type 1 diabetic patients are insulin
dependent requiring continuous basal supply of insulin which can be via subcutaneous insulin
injections or via insulin pump as in the case of my patient. This patient population needs optimal
perioperative glycemic management by experienced healthcare professionals (Patridge, Perkins,
Mathieu, Nicholls, & Adeniji, 2016). This leads to decreased adverse outcomes such as
hypoglycemia associated with intensive insulin therapy and diabetic keto acidosis commonly
seen with type 1 diabetic patients (Chiang, Kirkman, Laffel, Peters, & Type 1 Diabetes
Sourcebook Authors, 2014). These patients are also at risk for increased medical complications,
higher readmission rates or to be readmitted within 30 days after joint replacements
(Lovecchioer, Beal, Kwasny, & Manning, 2014).
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Glycemic control during the perioperative period for patients with type 1 diabetes can be
very challenging for clinicians leading to lengthened hospital stays, increased used of healthcare
resources, increased risk for perioperative and post-operative infections and greater perioperative
mortality compared to non-diabetic patients (Williams, 2007). Management challenges for type 1
diabetes mellitus during the perioperative period include lack of standardized diabetic care
guidelines within institutions, associated hypoglycemia or hyperglycemia, co-morbidities,
complexities with polypharmacy and insulin prescription errors and limited knowledge of
diabetic management among staff providing care to this patient population (Barker et al., 2015).
Adequate management of type 1 diabetic patients is therefore critical during the perioperative
period to prevent adverse patient outcomes, reduce mortality and save on scarce healthcare
resources.
Diabetic surgical patients usually fall into a higher risk category compared to nondiabetics, therefore optimizing perioperative management will require thorough evaluations to
minimize renal, cardiovascular and neurologic complications (Khan, Ghali & Cagliero, 2016). It
is therefore imperative for the health care team including surgeons, anesthesiologist and other
specialists who perform surgical procedures to have an in-depth knowledge of type 1 diabetes
and how it affects the overall care delivery process. Close glycemic monitoring perioperatively
will reduce microvascular and macrovascular complications in the type 1 diabetic patient. The
dilemma still remains as to what method is optimal in the perioperative management of adults
with type 1 diabetes to prevent adverse surgical outcomes. This case report will examine the
perioperative management of type 1 diabetics, some challenges clinicians encounter and how to
optimize care for this patient population.
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Case Report
Mr. JX is a pleasant 67 year old adult Caucasian male with type 1 diabetes mellitus who
presents to the clinic for a pre-operative evaluation for a right total knee arthroplasty/
replacement. Surgery has been scheduled to take place at the orthopedic hospital three weeks
from this pre-operative visit. About two months ago Mr. J.X. had a left total knee
arthroplasty/replacement and stated surgery was successful, but for issues with his blood sugars
“bottoming out during surgery,” needing urgent glycemic control and intervention. Patient has a
history of arthritis in both knees that has caused him significant discomfort, thus the need for
total knee replacements bilaterally. Patient says his right knee gets weak, causing constant pain,
aggravated with ambulation, and relieved by rest, using a cane for support or nonsteroidal antinflammatory drugs (NSAIDs) like ibuprofen. He had a fall 6 months ago, which was caused by
his right knee gave out. Patient denied any bruising or bleeding after fall.
Other pertinent past medical history include; hypertension, sleep apnea, hyperlipidemia,
diagnosed with type 1 diabetes in 1973 at age 6 years, carotid artery disease with about 60%
blockage bilaterally, left knee injury in 1970 during a football game stating “left knee was
clipped.” Patient denies any other heart diseases or respiratory problems. Patient denies any
allergies. He denies having any problems with anesthesia or family complications from
anesthesia. Significant surgeries include bilateral knee arthroscopes, left knee
replacement/arthroplasty, two hernia repairs and an appendectomy. Patient does not use any
home oxygen. Denies any recent acute or chronic infections. Patient denies bruising or bleeding
easily. He has no family history of bleeding or clotting disorders. Patient is independent at home,
has no trouble climbing stairs or a hill. He denies any shortness of breath or dizziness with
ambulation and walks his dog for about 2 miles daily. He also denies any recent chest pain,
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arrhythmias or congestive heart failure. Denies any history of Chronic Obstructive Pulmonary
disease or asthma.
Patient’s family/social history includes cardiovascular disease on father’s side. His father
died of a heart attack at age 69 years and his brother had a stroke. He also lost a brother to
esophageal cancer. Patient states he smokes a pack of cigarettes a day and is trying to quit.
Patient denies using any illicit drugs. Patient states he eats a balanced diet consisting of “meats,
potatoes and lots of fruits and vegetables.” For medications, patient is currently taking losartan
10mg, simvastatin 80mg, aspirin 81mg and multivitamins. He also has an insulin pump and
checks his blood sugars four times a day with numbers averaging 140mg/dl. Patient’s average
blood pressure at home are in the 130’s/80’s range. Patient had a normal stress test done a year
ago. Also says chest X-Ray was done in the past with no significant findings.
Patient’s physical exam was negative for wheezes, crackles, jugular vein distention,
carotid bruit or lower extremity edema. Significant findings during were a high blood pressure
reading of 158/94. Pre-operative labs and tests ordered during this visit include a complete blood
count with results of red blood cells slightly decreased at 3.0 10^6/uL and hematocrit at 34.5%
probably due to some blood loss from previous left total knee replacement done two months ago.
Patient’s comprehensive metabolic panel came back normal. EKG indicated a normal sinus
rhythm. With above elevated blood pressure readings, history of hypertension, and patient
scheduled for surgery in three weeks, elevated blood pressures will have to be addressed before
surgery.
The most significant plan for this patient included normalizing his blood pressure by
adding a beta blocker, such as metoprolol 25 mg with recommendations to keeping blood
pressure below 140/80 mmHg and monitor closely at home, reporting any abnormal readings
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before surgery. Patient will continue to monitor blood sugars at home and keep a log to be
reviewed before surgery. Lifestyle modifications such as quitting smoking especially before
surgery was discussed including benefit to overall health and patient outcomes given other
associated risk factors for stroke and coronary artery disease. He was encouraged to continue
heart healthy diet and daily exercises. Patient also informed to stop aspirin a week before surgery
to reduce risk of bleeding. Some expectations during the perioperative period such as hospital
length of stay, glycemic control and discharge were discussed with patient. After reviewing,
patient’s history, medications, labs, imaging, physical exam and plan, patient was cleared for
surgery.
Literature Review
According to the American Diabetes Association (2016), type 1 diabetes represents 5% of
all diagnosed diabetes cases, with diabetic patients accounting for a larger proportion of people
needing surgery, and have a higher perioperative risk for complications and longer hospital stays
compared to the nondiabetic population. About 21% of adults 60 years of age and older are
diagnosed with diabetes and is projected to double by 2025. The complexity of type 1 diabetic
patients during surgery can pose a challenge to clinicians needing careful assessment and
planning (Khan et al., 2016). It is therefore important to conduct thorough evaluations and
careful management during the perioperative period to prevent adverse outcomes postoperatively for type 1 diabetic patients.
A literature review was conducted to examine the perioperative, and post-operative
management of adults with type 1 diabetes outlining some challenges faced by clinicians. An in
depth search was conducted to review the most current literature using the University of North
Dakota’s Harley E. French Library of Health Sciences. PubMed was one of the online databases
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used to conduct a systematic search of literature with key word search using MeSH terms of type
1 diabetes AND intraoperatively within the last 5 years yielding 3 articles with two relevant
articles for my case report. Using PubMed, other MeSH terms like Perioperative AND
management AND diabetes mellitus, type 1, within the past 5 years yielded 17 articles with 6
articles being of relevance to my topic discussion. These 7 articles in their reference sections had
about 6 to 8 other relevant articles used for my literature review. The ADA grading system used
in the literature review range from A, B, C or E. A represents clear recommendations from well
conducted, generalizable randomized controlled trials that are adequately powered. B grade
means supportive evidence from well conducted cohort studies, C grade provides supportive
evidence from poorly or uncontrolled studies and E grade is expert consensus or clinical
experience (ADA, 2016).
The Importance of Managing Diabetes in the Surgical Setting
The stress of surgery and anesthesia has been known to activate the neuroendocrine
response, leading to a secretion of counter regulatory hormones such as cortisol and epinephrine,
impacting the action of insulin and predisposing the patient to ketoacidosis and hyperglycemia
(Rizvi, Chillag & Chillag, 2010). Hyperglycemia is also a risk factor for cerebral ischemia,
impaired wound healing, increased hospital stay.
According to Sudhakaran & Surani, (2015), recent evidence has shown that careful
glycemic control for diabetic patients undergoing major surgery including cardiac and orthopedic
procedures may decrease adverse surgical complications and lead to better patient outcomes.
Glycemic control in the perioperative setting especially for type 1 diabetics is done to recognize
hypoglycemia which if missed can result in a number of neurologic complications including
seizures, unconsciousness, somnolence, irreversible neurological insult and death. Sometimes
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recognizing the adverse neurological effects of hypoglycemia can be difficult post operatively
especially when the patient has been under anesthesia resulting in unrecognized hypoglycemia
for a critical length of time before proper glycemic correction is ensured (Sudhakaran & Surani,
2015). In order to optimize glycemic control and prevent adverse surgical outcomes during the
perioperative period, clinicians need to be vigilant and properly identify diabetes, glucose
intolerance, insulin resistance and associated diabetic diseases and comorbidities.
Preoperative Evaluation
Preoperative evaluation in the primary care setting for diabetes mellitus especially in type
1 diabetics is important in identifying risk factors, type of anesthesia to be used, improving
efficiency intraoperatively, reduce unnecessary testing and consultations, improving patient
education and satisfaction and decreasing perioperative complications.
During preoperative evaluations preoperative testing and laboratory evaluation should
include at least an electrocardiogram, a basic metabolic panel to assess renal function,
hemoglobin, electrolytes and hemoglobin A1c levels. Also knowing the type of diabetes and its
treatment must be considered as type 1 diabetics require continuous insulin therapy to prevent
diabetic ketoacidosis and hypoglycemia. Information of patient’s hemoglobinA1c may be
beneficial in not only classifying perioperative risk but to also determine care during the
postoperative phase. Asymptomatic diabetic patients who have cardiac risk factors such as
hypertension, tobacco use, or family history of cardiovascular disease should undergo cardiac
image/stress testing to rule out coronary artery disease before general anesthesia as an EKG
alone might not be sufficient in diagnosing silent coronary artery disease. The primary care
provider also needs to be familiar with the patient’s medications including mechanism of action
and those that are contraindicated during the perioperative period (Meneghini, 2009).
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The diabetic patient needing surgery should also be closely assessed preoperatively for
signs and symptoms of cerebrovascular, coronary artery disease and peripheral vascular disease.
Any comorbid health conditions must be identified and carefully managed perioperatively. Betablockers should be considered in diabetic patients with coronary artery disease to decrease risk of
perioperative ischemia. Preoperative goals for the type 1 diabetic surgical patient will be to
assess the patient’s overall health status, uncover conditions that can pose a problem during and
after surgery, determine the perioperative risk, optimize the patient’s medical condition to
decrease adverse surgical outcomes, formulate a concise perioperative plan of care and educating
the patient about what to expect during the perioperative and postoperative and discharge period
in order to reduce patient anxiety (Zambouri, 2007).
According to Koo, Hyder, Wanderer, Eikermann & Ramachandran (2015), the
perioperative risk assessment is done using the American Society of Anesthesiologists’
Classification of Physical Status. The ASA grading system which ranges from ASA class 1 to
class 6 according to severity of the patient’s disease state and E for emergency surgery, remains
one of the few prospective descriptions of the patient’s general health which correlates with the
risk of anesthesia and surgery. Koo et al., conducted a meta-analysis combining 77 studies and
165,705 patients to predict the accuracy of postoperative mortality using the ASA physical status
classification and found that even though it was a better predictor of postoperative mortality, it
was more effective in settings with lower than higher death rates (Koo et al., 2015). My patient
will be considered to be an ASA class II as patient underneath this category are those with mild
systemic disease.
A study by Hollenberg and colleagues found that diabetes is one of the five independent
risk factors for postoperative myocardial ischemia and insulin-independent diabetes is one of the
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five clinical risk factors on the Revised Cardiac Risk Index and this index looks for major
cardiac complications, including cardiac arrest, myocardial infarction, heart failure and heart
block. The preoperative assessment of cardiac risk is done according to the American College of
Cardiology/American Heart Association guidelines (Miller & Richman, 2016).
A retrospective observational study was conducted by Kallio et al. (2015) to test the
hypothesis that anesthesia preoperative clinic referral for elevated glycosylated hemoglobin
reduces complication rates after total joint arthroplasty. The total number of patients in this study
was 203 with and without DM selected from 1,237 patients undergoing TJA from 2006 to 2012.
Patients who were evaluated in the anesthesia preoperative clinic had surgery in 2006 to 2008
irrespective of HbA1c. Patients evaluated in two year intervals were referred to primary care for
HbA1c greater than 10% and 8% respectively to improve glycemic control before surgery.
Complications and mortality were quantified postoperatively at three, six and twelve months.
Length of stay and prolonged stays (greater than 5 days) were recorded. The results of this study
showed that patients undergoing TJA with uncontrolled HbA1c and those with HbA1c less than
10% but not those with HbA1c less than 8% had a higher incidence of coronary artery disease
and hypercholesterolemia and increased complication rates than patients without DM. Also
complication rates significantly decreased with tighter HbA1c control. The study saw an increase
in prolonged hospital stay for DM patients with uncontrolled HbA1c greater than 10% versus
those without DM. From this study we see the importance in referring DM patients to primary
care providers for preoperative evaluations as it reduced complications rates and the incidence of
prolonged hospitalizations during the first year after surgery in diabetics undergoing TJA.
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Perioperative Glycemic Management
There is an increased mortality for diabetics undergoing surgery, especially Type 1
diabetics who are particularly at risk for postoperative complications. The successful
management of the type 1 diabetic patient during surgery therefore requires safe and simple
protocols that can be understood by all staff to decrease surgical errors and optimize glycemic
control.
There have been several management strategies proposed to maintain target range
glucose perioperatively, but there is no consensus as to what strategy remains optimal. According
to Khan et al. (2015), most protocols for insulin administration have been formulated by expert
opinion and clinical experience. Decisions as to which strategy to use will depend on the hospital
setting, individual patient, resources and clinician judgement. In a meta-analysis of 12
randomized trials, with 1,403 diabetic patients, intensive (<120 or <150mg/dL) versus
conventional (variable) glycemic control during the perioperative period, intensive glycemic
control perioperatively was not associated with any reduction in infectious complications,
cardiovascular events or mortality but had an increased risk for hypoglycemia. In this study the
mean difference for achieving blood glucose levels between the intensive and conventional
group ranged from -13 to 91 mg/dL (0.72 to 5.0 mmol/L) (Khan.,Ghali.,Cagliero,2015).
Buchleitner et al., in a systemic review identified 12 trials randomizing 694 diabetic
participants to the intensive control group and 709 diabetic participants to the conventional
glycemic control group, with mean age at 64 years. Duration of intervention ranged from the
duration of the surgical procedure up to 90 days. Despite achieving low blood glucose
concentrations during the perioperative period, intensive glucose control did not significantly
reduce the risk of important postoperative outcomes such as infections, cardiovascular
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complications, renal failure or increased hospital stay. However intensive glycemic control was
associated with increased hypoglycemia episodes in diabetic patients in the intensive glycemic
group. The authors came to the conclusion that intensive glycemic control protocols with blood
glucose near normal targets for patients with diabetes mellitus undergoing surgical procedures
are currently not supported by an adequate scientific basis. For the future studies, these authors
recommend that insulin protocols, patient and healthcare outcomes should be defined in a
thorough and uniform way (Buchleitner et al., 2012).
Another study by Van den Berghe and colleagues on intensive insulin therapy in the
surgical intensive care unit showed that patients demonstrated a major reduction in morbidity and
mortality when glucose levels were controlled strictly, ranging from 80 to 110mg/dL, averaging
103 mg/dL, compared with conventional control of 180 to 200 mg/dL. The study also
demonstrated benefits of intensive glycemic control which was seen to reduce outcomes such as
sepsis, need for dialysis, need for blood transfusion and the development of polyneuropathy.
Intensive insulin therapy also led to cost saving compared to conventional insulin therapy
(Meneghini, 2009).
Finfer et al. (2009), designed a Normoglycemia in Intensive Care Evaluation-Survival
Using Glucose Algorithm Regulation (NICE-SUGAR) trial to test the hypothesis that intensive
glucose control reduced mortality at 90 days. A randomized controlled trial included adult
medical and surgical patients admitted to the ICU of 42 hospitals were assigned to an intensive
control target (81 to108 mg/dL) and a conventional control target of 180 mg/dL or less. Blood
glucose control was obtained with use of an intravenous infusion of insulin and saline. Blood
glucose measurements were obtained by arterial blood gas analyzers, laboratory analyzers or by
point-of-care. Use of capillary sample were discouraged. Results of this study showed that 206
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out of 3,016 patients in the intensive control group experienced severe hypoglycemia (blood
glucose <40mg/dL) compared to 15 of the 3,014 patients in the conventional control group.
There was also no significant difference between the two treatment groups in regards to the
average number of days in the ICU, hospital or renal-replacement therapy. This study therefore
concludes that there is an increase in mortality among ICU adult patients with intensive glucose
control of 81 to 108 mg/dL compared to lower mortality when blood glucose targets are
180mg/dL or less (Finfer et al., 2009).
However, the Society for Ambulatory Anesthesia states that even though hyperglycemia
may be linked to increased morbidity and mortality in diabetic patients undergoing major
surgery, several randomized controlled trials evaluating tight perioperative glycemic control (80
and 110mg/dL) have reported inconsistent results, with some studies reporting harm to patients.
Tight control warrants frequent blood glucose monitoring making glycemic management more
complex. Regardless of the above studies, major professional organizations such as the Centers
for Medicare and Medicaid Services, recommend tight glycemic perioperative control as a
national quality improvement initiative (Joshi et al., 2010).
Despite differences with above findings most of the author’s main goal for the
perioperative period is to avoid hypo or hyperglycemia and maintain adequate blood glucose
control to decrease morbidity and mortality in the diabetic patient especially the adult type 1
diabetic patient.
Sudhakaran and Surani, (2015), in light of recent research have proposed perioperative
management guidelines for the diabetic patient. Type 1 diabetic patient need to continue a basal
insulin replacement preoperatively (0.2 to 0.3 U/kg/day) of a long acting insulin. For
intraoperative glycemic management, even though there is no consensus for target range, current
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literature suggest keeping blood glucose levels between 150 and 200 mg/dL during surgery. This
is due to studies that have found increased morbidity and mortality with intraoperative
hyperglycemia (glucose above 200mg/dL) as well as relative normoglycemia (glucose less than
140mg/dL) also found to be associated with significant mortality and morbidity.
Khan et al, 2015, suggest that for short procedures lasting less than 2 hours, type 1
diabetic patients who use insulin can continue subcutaneous insulin perioperatively rather than
an insulin infusion. For morning procedures patients should also delay taking their morning
insulin until after surgery and before they eat. Patients who are on continuous insulin pumps may
continue their basal insulin without any changes to their regular regiment given that their basal
insulin dose can be calculated correctly, with catheter and pump remaining safely in place during
surgery. Preoperative hypoglycemia can be avoided in patients with a known history of
hypoglycemia as an outpatient by reducing their basal rate by 10 to 20%.
Khan et al., 2015 recommend that for long complex procedures, IV insulin is
usually required. Studies have compared the use of subcutaneous insulin versus IV infusion and
found a significant increase in the variability of the glucose concentration when using the
subcutaneous route, attributed to different rates of insulin absorption when hypothermia,
vasoconstriction or hypoperfusion occurs. Many studies have shown the safety of IV insulin
infusions in highly monitored settings. Also insulin infusions can be more readily titrated due to
its short half-life of IV insulin (5 to 10 minutes), enabling more precise glucose control. With IV
insulin infusions, blood glucose should be monitored every hour and more frequently if blood
glucose levels are <100mg/dL or it rates fall rapidly which can be an indication for
hypoglycemia. Preferred method for intraoperative glucose testing is by laboratory or point of
care testing, not finger stick glucose levels as they are less reliable. For sedated anesthetized
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patients, with a blood glucose less than 70 mg/dL IV dextrose 25mg is administered and repeat
glucose measurements in 5 to 10 minutes. In the awake patient that can swallow, symptomatic
hypoglycemia is treated with at least 15 g of carbohydrate. (Khan et al. 2015)
The American Association of Clinical Endocrinologist and the ADA, 2009,
recommend that IV infusion therapy be administered by means of validated protocols or
computerized protocols enabling adjustments in insulin infusion rates based on glycemic
fluctuations and insulin dose. They emphasize on the fact that systems put in place to ease the
appropriate use of scheduled insulin therapy, with institutional support for inpatient personnel
who are knowledgeable in glycemic management are important for achieving safe and
reasonable levels of glycemic control in hospitalized diabetic patients. A Portland Diabetic
project, a 17 year prospective nonrandomized study of 4,864 patients with diabetes who
underwent open-heart surgery, the implementation of a continuous IV insulin therapy to achieve
predetermined target BG levels reduced the incidence of deep sternal wound infections by 66%
resulting in a total net savings to the hospital of about 4,638 USD per patient (Furnary, Wu &
Bookin, 2004; Moghissi et al., 2009).
Most recent recommendations form the American Diabetes Association (2016) about
diabetes care in hospitals, recommend initiating insulin therapy for persistent hyperglycemia
with blood sugars levels above 180mg/dL for critically ill patients and with target range of 140180 mg/dL with a grade recommendation of grade A. Tighter glycemic control may be needed
for specific critically ill patients such as 110-140mg/dL as long as hypoglycemia can be
prevented. Insulin infusion should be administered using validated or written or computerized
protocols that allow for predefined adjustments of insulin (E grade). Hypoglycemia management
protocols should be developed by each hospital with individualized plans to prevent
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hypoglycemia for each patient (Grade E). The ADA, in their recent recommendations have also
agreed that tight glycemic control from research studies has led to increased mortality versus
moderately controlled cohorts and have reflected these glycemic changes mentioned above for
diabetic hospitalized patients. Tight glycemic control is therefore reserved for patients with a
successful history in an outpatient setting who are stable clinically and can be maintained with
glucose levels less than 140mg/dL (ADA, 2016)
Patridge et al. (2016), place clear emphasis the fact that hospitals and health care
organizations have to come up with clear, concise and standardized national and international
guidelines for inpatient management of type 1 diabetic patients with insulin pumps during
surgery. As of yet most of recommendations are based on case reports with little evidence
available to drive these recommendations as they are still non-standardized and based on local
guidelines. With very limited research, on the use of insulin pump therapy during the
perioperative period, the Joint British Diabetes Society (JBDS) have offered a set of guidelines
and recommendations for the management of type 1 diabetes perioperatively.
The JBDS recommend that type 1 diabetic patients on insulin pumps undergoing surgery
need to be reassured depending on the type of surgery that they will be receiving similar insulin
therapy either through IV insulin or the form of multiple daily injections. Elective surgery for
type 1 diabetic patients with adequate planning with the diabetic is recommended with HbA1c
less than 8.5% using models like the Bournemouth diabetes surgical pre-assessment service to
prevent micro and macrovascular complications. The JBDS also recommend that patients
continue to use their insulin pumps and regiments for elective procedures while following
instructions regarding fasting by the anesthetic team. Patridge et al, 2016 reviewed other
recommendations from Australia recommending patients use 80% basal insulin rates upon

MANAGEMENT OF TYPE 1 DIABETES PERIOPERATIVELY

19

initiation of surgery used on a temporary basis and resumed to normal upon consciousness and
when patient is able to manage their blood sugars. These conflict with recommendations from the
United Kingdom for surgery as they recommend patients to continue their insulin at a 100%
basal rate due to basal rate assessments done during the pre-operative assessment.
The JBDS also recommend the discontinuation of insulin pumps during major surgery
replacing it with IV insulin which is started at least halve an hour before discontinuing patient’s
insulin pump. They also strongly advise against using continuous glucose monitor devices
attached to insulin pumps as a means of checking blood glucose during surgery due to
discrepancies (Partridge et al., 2016).
Similar to other recommendations mentioned in the literature review it is strongly
recommended that blood glucose be checked every hour preoperatively, perioperatively and
postoperatively. As with other studies, Patridge et al, also assert that adequate glycemic targets
during major and minor surgeries have been controversial as studies conducted by Van den Bergh
proposing for tighter and conservative glycemic control (80-110 mg/dL), improving mortality
compared with a more conservative approach have not been supported by the NICE-SUGAR
study that opted for a more conservative blood sugar target, between 6mmol/l (108mg/dL) to
10mmol/l (180mg/dL).
Despite recommendations, studies, and epidemiologic studies, associating poor clinical
outcomes to hypoglycemia, data show that insulin-induced hypoglycemia as causing direct harm
to hospitalized patients is scarce. The strategies discussed above, even though effective have not
been proven to optimally reduce outcomes of morbidity or mortality and the length of hospital
stays. Many of the management strategies above require further investigation
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Postoperative Glycemic Management
Due to effects from anesthesia, and other postoperative complications, glycemic control
during the postoperative phase for type 1 diabetic patients can pose a challenge to clinicians. To
minimize postoperative complications diligent blood glucose management is very important.
During the postoperative phase, patients are usually transitioned to subcutaneous insulin
when they begin eating or are transferred in to a lower-intensity of care after IV insulin infusions.
Subcutaneous insulin must be administered 1-4 h before the discontinuation of IV insulin therapy
to prevent hyperglycemia is the preferred methods of maintaining blood glucose control in the
non-critical, non-ICU setting .With these recommendations, these authors note that “an effective
transition regime has not been substantiated” (Moghissi et al.,2009). Recommendations by Khan
et al, 2015, indicate continuation of insulin infusion postoperatively for patients who do not
resume eating postoperatively and once food is tolerated they can be switched to subcutaneous
insulin or insulin pump based on their outpatient regime to complement what is being eaten. It is
important that basal insulin levels remain stable after intraoperative IV insulin discontinuation
for type 1 diabetic patients to prevent diabetic ketoacidosis. Meanwhile there is no clear
consensus on postoperative management other sources recommend the transition from IV to
subcutaneous insulin 12 to 24 hours prior to stopping the insulin drip to reduce the change of
diabetic ketoacidosis in type 1 diabetic patients (Sudhakaran & Surani,2015). The Society of
Thoracic Surgeons as well as the AACE/ADA consensus recommend that postoperative glycemic
ranges be between 140 to 180mg/dL. (Sudhakaran and Surani, 2015). The authors above from
recent literature and recommendations all agree on adequate and safe glycemic control in the
postoperative period while maintaining stable basal insulin levels for type 1 diabetics to prevent
adverse outcomes such as diabetic ketoacidosis. All articles reviewed did not show a clear
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consensus or any main optimal glycemic management during the postoperative period for type 1
diabetics.
Patridge et al. (2016), in regards to postoperative recommendations from the JBDS allow
for hourly blood sugar checks until patients are fully conscious to make decisions regarding their
insulin pumps. Also aware of post hyperglycemia for the conscious patient an hour or two hours
after surgery the patient’s insulin pump built in bolus calculator should be able to adjust the
correct insulin dose needed to bring down the patient’s blood glucose. Patients are also strongly
encouraged to frequently monitor their blood sugars 1 to 2 days after surgery to re-establish their
baseline status. These authors suggest that there have been studies showing benefits of lower
fasting glucose on the first day postoperatively and more stable blood glucose in patients
remaining on insulin pump therapy during elective surgery than those on non- insulin pump
therapy even though trial designs and data in other studies remain ambiguous and in conclusive.
Transitioning the patient to the outpatient setting takes the responsibility from the
hospital personnel to self-management by the type 1 diabetic patient. During the discharge
process, successful transition requires a team approach by the endocrinologists, nurses,
dieticians, diabetic educators’ case managers social workers and other involved clinicians. Before
discharging patient to the home setting, certain areas such as understanding diabetes diagnosis,
self- monitoring of BG at home, recognition, treatment and prevention of hyper or
hypoglycemia, diet, how to administer BG lowering medications or ongoing management if on
insulin pump will be very important to review with the patient (Moghissi et al,2009). This is
done to identify areas of knowledge deficits in the type 1 diabetic patient so they can be better
educated prior to discharge, leading to better self-management at home.
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The ADA (2016) recommend follow up visit within one month post discharge for all
diabetic patients who experienced hyperglycemia in the hospital with the patients primary care
provider or endocrinologist. There should also be hospital guidelines to resume patient’s
medication regiment one to two days before discharge.
Learning Points


In the primary care setting, preoperative evaluations for the type 1 diabetic adult patient
needing surgery are vital evaluations as they identify important risk factors before
surgery that that if missed can lead to adverse surgical outcomes. During this stage care
coordination, medication reconciliation and management of presenting health problems
are addressed which has led to a reduction perioperative and postoperative morbidity and
mortality.



Overtreatment or under treatment of hypoglycemia still remains a major safety concern
during the perioperative and post-operative management of Type 1 diabetic patients and
can be very challenging for clinicians. Proper identification of high risk patients is vital in
the overall perioperative and postoperative management phase to prevent adverse surgical
outcomes.



Clear guidelines and protocols need to be developed by hospitals for the inpatient
management of type 1 diabetic patients on insulin pumps with in service and education
for all healthcare providers who are most likely to encounter these group of patients, in
close collaboration with the diabetes team such as the endocrinologist and insulin pump
nurse specialist.



Intensive glycemic control programs for inpatient glycemic control for type 1 diabetic
patients is backed by current evidence based research (even though studies reveal
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conflicting data). Tight glycemic control appears to result in fewer in patient
complications, reduced ICU and hospital stays, significant decreased morbidity and
mortality and decreased cost.


Proper discharge planning, thorough patient education and clear communication among
the interdisciplinary team members and outpatient providers is critical in accomplishing a
safe and successful transition to outpatient glycemic management.
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